Promino Nutritional Sciences Inc. MUSLF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.23M | 1.48M | 1.55M | 1.23M | 719.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.23M | 1.48M | 1.55M | 1.23M | 719.90K |
| Cost of Revenue | 1.15M | 1.25M | 1.23M | 1.13M | 811.60K |
| Gross Profit | 83.00K | 230.20K | 323.80K | 106.70K | -91.60K |
| SG&A Expenses | 2.19M | 2.36M | 2.46M | 531.20K | 1.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.35M | 3.63M | 3.70M | 1.69M | 2.18M |
| Operating Income | -2.12M | -2.14M | -2.15M | -458.50K | -1.46M |
| Income Before Tax | -1.76M | -2.07M | -2.14M | -807.10K | -2.31M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.76 | -2.07 | -2.14 | -0.81 | -2.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.76M | -2.07M | -2.14M | -807.10K | -2.31M |
| EBIT | -2.12M | -2.14M | -2.15M | -458.50K | -1.46M |
| EBITDA | -- | -- | -- | 972.00K | -400.60K |
| EPS Basic | -0.01 | -0.01 | -0.02 | -0.01 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.02 | -0.02 | -0.01 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 630.72M | 572.92M | 527.05M | 505.52M | 469.06M |
| Average Diluted Shares Outstanding | 630.72M | 572.92M | 527.05M | 505.52M | 469.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |